BRPI0924168A2 - estrutura sólida feita de pó de osso e cola de fibrina - Google Patents

estrutura sólida feita de pó de osso e cola de fibrina

Info

Publication number
BRPI0924168A2
BRPI0924168A2 BRPI0924168A BRPI0924168A BRPI0924168A2 BR PI0924168 A2 BRPI0924168 A2 BR PI0924168A2 BR PI0924168 A BRPI0924168 A BR PI0924168A BR PI0924168 A BRPI0924168 A BR PI0924168A BR PI0924168 A2 BRPI0924168 A2 BR PI0924168A2
Authority
BR
Brazil
Prior art keywords
structure made
solid structure
fibrin glue
bone powder
bone
Prior art date
Application number
BRPI0924168A
Other languages
English (en)
Inventor
Dong-Hyeon Yoon
Jun Lee
Original Assignee
Industry Academic Cooperation Foundation Wonkwang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation Wonkwang University filed Critical Industry Academic Cooperation Foundation Wonkwang University
Publication of BRPI0924168A2 publication Critical patent/BRPI0924168A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
BRPI0924168A 2009-01-16 2009-02-02 estrutura sólida feita de pó de osso e cola de fibrina BRPI0924168A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090003884A KR100932945B1 (ko) 2009-01-16 2009-01-16 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드
PCT/KR2009/000507 WO2010082702A1 (ko) 2009-01-16 2009-02-02 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드

Publications (1)

Publication Number Publication Date
BRPI0924168A2 true BRPI0924168A2 (pt) 2016-02-10

Family

ID=41684485

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924168A BRPI0924168A2 (pt) 2009-01-16 2009-02-02 estrutura sólida feita de pó de osso e cola de fibrina

Country Status (11)

Country Link
US (1) US20110270408A1 (pt)
EP (1) EP2388020A4 (pt)
JP (1) JP2012515041A (pt)
KR (1) KR100932945B1 (pt)
CN (1) CN102264401A (pt)
AU (1) AU2009337223A1 (pt)
BR (1) BRPI0924168A2 (pt)
CA (1) CA2746582A1 (pt)
MX (1) MX2011007193A (pt)
RU (1) RU2011118071A (pt)
WO (1) WO2010082702A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101539822B1 (ko) * 2012-05-14 2015-07-29 서울대학교산학협력단 줄기세포의 3차원 배양을 통한 고농축 배양액의 제조방법 및 고농축 배양액의 용도
KR101456642B1 (ko) 2012-06-20 2014-11-03 주식회사 본셀바이오텍 피브리노겐이 코팅된 골 분말을 포함하는 골 재생용 조성물 및 이의 제조 방법
US9034044B2 (en) * 2012-09-13 2015-05-19 H & M Innovations, Llc Bone infusion apparatus and methods for interbody grafts
KR101540691B1 (ko) * 2013-01-09 2015-07-31 원광대학교산학협력단 피브리노겐, 아프로티닌, 리도카인, 에피네프린 및 콜라겐 막을 포함하는 서방성 국소 약물전달체, 키트 및 이를 이용한 골병증 치료용 조성물
KR101626347B1 (ko) * 2015-06-05 2016-06-01 주식회사 디오 골유도재생블록 제조방법
CN105154397A (zh) * 2015-07-09 2015-12-16 深圳爱生再生医学科技有限公司 Cik的制备方法
CN109717969B (zh) * 2017-10-30 2021-11-02 江西丝科生物科技有限公司 一种基因重组蜘蛛丝蛋白牙齿嵌体及其制备方法
CN109700576A (zh) * 2019-01-18 2019-05-03 孟兵 一种利用干细胞、天然纤维进行颅骨修补的技术
CN110947031B (zh) * 2019-09-25 2022-04-05 中山大学附属第八医院（深圳福田） 一种具有高生物活性的骨组织工程支架材料及其制备方法和应用
KR102273121B1 (ko) * 2020-06-26 2021-07-06 주식회사 덴하우스 골 재생용 주입형 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US5776193A (en) 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
US5914121A (en) 1997-02-12 1999-06-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Formation of human bone in vivo using ceramic powder and human marrow stromal fibroblasts
US6696073B2 (en) * 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
DE19956503A1 (de) 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
US7074412B2 (en) * 2003-01-30 2006-07-11 The University Of Zurich Pharmaceutical composition
CA2514474C (en) * 2003-01-30 2014-05-06 Avner Yayon Freeze-dried fibrin matrices and methods for preparation thereof
JP2008513100A (ja) * 2004-09-14 2008-05-01 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 多孔度生体材料−充填剤複合体およびその製法
US20060216321A1 (en) * 2005-03-24 2006-09-28 Sdgi Holdings, Inc. Solvent based processing technologies for making tissue/polymer composites
KR100702250B1 (ko) * 2005-06-13 2007-04-03 세원셀론텍(주) 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법
WO2007126411A2 (en) * 2005-07-28 2007-11-08 Carnegie Mellon University Biocompatible polymers and methods of use

Also Published As

Publication number Publication date
RU2011118071A (ru) 2015-04-10
US20110270408A1 (en) 2011-11-03
WO2010082702A1 (ko) 2010-07-22
CA2746582A1 (en) 2010-07-22
EP2388020A4 (en) 2014-01-15
CN102264401A (zh) 2011-11-30
KR100932945B1 (ko) 2009-12-21
JP2012515041A (ja) 2012-07-05
EP2388020A1 (en) 2011-11-23
AU2009337223A1 (en) 2011-07-28
MX2011007193A (es) 2011-07-28

Similar Documents

Publication Publication Date Title
BRPI0924168A2 (pt) estrutura sólida feita de pó de osso e cola de fibrina
EP2515946A4 (en) NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS
BRPI0906980A2 (pt) Composição de derivados e maleatados
IL219085A (en) Solid precursor delivery assemblies and related methods
BRPI0908948A2 (pt) preparação de materiais de dessulfurização
EP2424488A4 (en) MICRO-SECONDED COMPOSITIONS AND METHOD FOR TISSUE ANALYSIS
PT2496691T (pt) Composições de nucleases terapêuticas e métodos
PL2427212T3 (pl) Przeciwciała anty cd-100 i sposoby ich zastosowania
PT2376533T (pt) Formulação de anticorpos
EP2632272A4 (en) BIOACTIVE CHROMACTERIAL COMPOSITIONS AND METABOLITES THEREOF
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI0913398A2 (pt) composição e métodos de adesivo para dentaduras
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
EP2429699A4 (en) DENSITY MODIFICATION
PL2493466T3 (pl) Nowe przeciwguzowe zastosowanie kabazytakselu
IL208979B (en) Humanized antibodies against human interferon-alpha
BRPI1015471A2 (pt) ativador de gel relaxante
EP2457933A4 (en) LATEX AND LABELING COMPOSITION THEREOF
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme
PT2504298T (pt) Preparação e purificação de iodoxanol
BRPI1014688A2 (pt) aplicações terapêuticas de derivados de quinazolinadiona
EP2433996A4 (en) LIQUID COMPOSITION AND ENDOSCOPE
BRPI1006953A2 (pt) composição farmacêutica, e, uso de uma composição
BR112012014277A2 (pt) fabricação e montagem de artigos absorventes com múltiplos componentes impressos

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: INDUSTRY-ACADEMIC COOPERATION FOUNDATION WONKWANG

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 20120005471 DE 23/01/2012, E NECESSARIO CITAR NO DOCUMENTO DE CESSAO O PEDIDO QUE ESTA SENDO CEDIDO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2377 DE 26-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25B Requested transfer of rights rejected

Owner name: INDUSTRY-ACADEMIC COOPERATION FOUNDATION WONKWANG

B350 Update of information on the portal [chapter 15.35 patent gazette]